Skip to main content
. 2019 Feb 20;8(5):e1576490. doi: 10.1080/2162402X.2019.1576490

Figure 6.

Figure 6.

Citrullinated peptides provide efficient therapy of lung tumours. HLA-DP4 (a) or HLA-DR4 (b) transgenic mice were challenged with LLC/2 cells constitutively expressing HLA-DP4 or HLA-DR4. Four days later mice were immunised with citrullinated Vim28-49, Vim415-433 and Eno241-260 peptides and tumour growth monitored. Tumour growth curves (i) and tumour volume (ii) in the HLA-DP4 model at day 15 and in HLA-DR4 model at day 16 are shown. N = 10/group.